Gilead Sciences 2014 Annual Report Download

Download and view the complete annual report

Please find the complete 2014 Gilead Sciences annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 5

  • 1
  • 2
  • 3
  • 4
  • 5

Gilead Annual Report 2014

Table of contents

  • Page 1
    Gilead Annual Report 2014

  • Page 2
    ... Operating Officer; John C. Martin, PhD, Chairman and Chief Executive Officer; Norbert W. Bischo erger, PhD, Executive Vice President, Research and Development and Chief Scientific Officer; Katie L. Watson, Senior Vice President, Human Resources; Paul R. Carter, Executive Vice President, Commercial...

  • Page 3
    ... the company's pipeline of experimental oncology medicines is GS-4059, a BTK inhibitor we recently licensed from Ono Pharmaceutical of Japan. With this agreement, Gilead now has compounds targeting multiple signaling pathways associated with B-cell malignancies-PI3K delta, Syk, JAK and BTK. The...

  • Page 4
    ... Scripps Research Institute CORPORATE SECRETARY Gregg H. Alton Executive Vice President, Corporate and Medical Affairs INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS Ernst & Young, LLP Redwood City, California CORPORATE HEADQUARTERS Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 USA (800...

  • Page 5
    Gilead Sciences, Inc. 333 Lakeside Drive Foster City, California 94404 650 574 3000 T 800 445 3235 650 578 9264 F www.gilead.com